Scimagix Agrees to Resell Compugen s Z3 Gel Analysis Tool | GenomeWeb

NEW YORK, Feb 21 – Scimagix, a Redwood Shores, Calif.-based bioinformatics company, said Wednesday it had agreed to serve as a reseller of Compugen’s Z3 system, which is used for analyzing 2-D electrophoresis gels.

Scimagix said it would sell Z3 along with its Scientific Image Management System, which stores, retrieves, and analyzes protein images. Scimagix and Compugen of Tel Aviv have also agreed to work together to integrate their products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.